Virtual Medicinal Product (VMP) - Amphotericin B (lipid formulation) 50mg/10ml suspension for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Amphotericin B (lipid formulation) 50mg/10ml suspension for injection vials Start Date 11-10-2007 End Date
Previous Name Previous Name Amphotericin (lipid formulation) 50mg/10ml suspension for injection vials Start Date 31-10-2005 End Date 10-10-2007

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
10
UDFS UOM
ml
Unit Dose UOM
vial

Summary

Invalid
Prescribing Status
Caution - AMP level prescribing advised
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous
Form
Suspension for injection
Ontology Form/Route
suspensioninfusion.intravenous
Non-availability Indicator
Actual Products not Available
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
J02AA01
BNF Start Date End Date
Previous BNF 05020000 Start Date 31-10-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
419072007 01-11-2006
9730911000001100 31-10-2005 31-10-2006

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Amphotericin B phospholipid complex Based on Base Substance Amphotericin B 5 mg 1 ml

Parent Products

  • VTM
    No Parent VTM
    • VMP
      (Current) Amphotericin B (lipid formulation) 5...
      • AMP
        No AMP's

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
10 vial